All

A blog about science

A potential target to stop Zika from replicating

Zika virus outbreak is a global emergency since 2016. A recent publication from Anton et al. 2021, has set in evidence some vulnerabilities that could be targeted. In their study they have asked us for a custom antibody project to allow them to study one of their proteins of interest.

MédiMabs’ Team

Feb 26 • 5 min

Latest articles

Akt activation pathway

Akt is a subfamily of serine/threonine kinases (Protein Kinase B) that includes AKT1, AKT2, and AKT3. Akt resides in the...

MédiMabs’ Team • Oct 26 • 2 minutes read

IDIGH symposium and product show

Infectious Diseases and Immunity in Global Health Program (IDIGH) has been developed at McGill University to maximize the research effort with...

MédiMabs’ Team • Oct 18 • 2 minutes read

Montreal Immunology Meetings

Montreal Immunology Meetings are a local initiative from researchers in immunology related fields. They organize small presentations from experts on...

MédiMabs’ Team • Oct 12 • 1 minutes read

DDRs, a family of 2 proteins, are key in cell-to-microenvironment communication

The cellular microenvironment can modulate intracellular pathways, these interactions can occur in normal or physiopathological conditions. However, if pro-survival molecules...

MédiMabs’ Team • Oct 03 • 2 minutes read

MédiMabs is presenting StabiliMABS

StabiliMABS is a two part option you can apply on any custom hybridoma project. We would first apply StabiliMABS-1 on early positive clones...

MédiMabs’ Team • Sep 27 • 2 minutes read

EGFRs in cancer

Epithelial Growth Factor Receptors are a family of receptor tyrosine kinase well studied for their role in cancer. (1) They have been...

MédiMabs’ Team • Sep 27 • 2 minutes read

SOD1 and ALS

The discovery of the implication of SOD1 mutants in familial ALS has turned 25 this year.(1) ALS was discovered more than 100 years...

MédiMabs’ Team • Sep 19 • 2 minutes read

CRCHUM show October 11th 2018

It will be our pleasure to meet you at our booth during the Biotech-connect event on October 11th at the CRCHUM in Montréal. We will...

MédiMabs’ Team • Sep 19 • 1 minutes read

Neurosciences

Research on neurodegenerative disease has always been important at MédiMabs. Partly because two of our founders have dedicated their career to this...